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Combining the increase demand for natural products in skin care formulations, and the bioactive arsenal of 
cyanobacteria, we aimed with this study to evaluate the potential of a 70% ethanolic extract of 
picocyanobacteria strains of the genera Cyanobium and Synechocystis for skin care applications. The 
cyanobacteria extract was analyzed for the phytochemical profile including carotenoid and phenolic 
content, for the antioxidant potential, and for the in vitro cytotoxicity against keratinocytes (HaCat), 
fibroblasts (3T3L1) and endothelial cells (hCMEC/D3). The total carotenoid content ranged from 162.43 to 
383.89 µg g-1 of dry biomass and the total phenolic content (TPC) from 1.09 to 2.45 mg GAE g-1. Identified 
carotenoids consisted in zeaxanthin, lutein, canthaxanthin, echinenone and β-carotene, being zeaxanthin 
and lutein the most representative (49.82 and 79.08 µg g-1, respectively). The antioxidant potential assessed 
by the DPPH• and superoxide anion radical (O2•-) scavenging assays resulted in an IC50 of 863.82 µg mL-1 and 
1275.86 µg mL-1 respectively. An increase in cell viability was registered, particularly for fibroblasts and 
keratinocytes. From all the strains, both the species Synechocystis salina LEGE06099 and Synechocystis 
salina LEGE06155 evidenced an interesting potential for further exploitation.  
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